Galectin Therapeutics 10K 2005 Annual report | GALT Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: accurate, agency, allocable, Alzheimer, analyzed, anomeric, Aptium, argument, arising, array, automobile, backbone, bearing, bile, blackout, bloodstream, branching, broaden, broadly, bypassing, calendar, categorize, cellular, CEO, chain, Chapter, charter, cholangiocarcinoma, clearance, clinicaltrial, constant, cured, cycle, davanat®, de, Debenture, deciphered, default, degradation, Description, diagnosed, diameter, duct, EMEA, enzymatic, evidencing, extraordinarily, factor, flat, galactomannan, galactose, Gene, Guar, gum, healthcare, incurrence, ineligibility, infection, inflammatory, inflow, isolated, Journal, kind, lapse, lectin, linkage, ll, lll, long, longest, lowest, mannose, men, microbial, open, orientation, overhead, owing, Oxley, partnership, payroll, PCT, penalty, petition, physiological, play, precautionary, precisely, receptor, RECIST, recovery, redemption, relevant, repay, replace, residue, secreted, shape, shareholder, shifted, shorter, shrinkage, signal, smallest, spending, stayed, subdivide, sum, summary, superceeded, suspend, Tetragonoloba, thereon, thereunder, translate, transmission, unacceptable, unambiguously, unavailable, understood, unpaid, unrecognized, untapped, USPTO, variation, vast, viral, women

Removed: abnormal, absorption, achieved, acid, acquirer, acute, addressed, adhere, Adriamycin, affiliated, Alabama, anorexia, anticancer, apparent, avoid, bachelor, Bedford, bid, Birmingham, bladder, bleeding, bone, breathing, budgetary, buildup, capture, carcinoma, characterized, chemically, circulation, clear, collect, commencement, commitment, compatibility, contemplate, contracted, Cooperation, covering, cyclophosphamide, cytotoxic, Cytoxan, darkening, death, decreasing, deficiency, define, delivering, dense, deprivation, diarrhea, diet, dismissed, DNA, dramatically, drop, EDC, electronic, emotional, enabling, encouraging, enhance, enhancement, environment, envision, escalation, essentially, exclusively, extend, extending, extreme, fact, favorably, female, fluid, fluorinated, folinic, foregoing, forming, found, frequency, functional, Galactomycin, generic, genetic, Good, grow, Haifa, half, heart, hypersensitivity, immune, implanted, implement, improved, incorporate, index, individually, informal, inhibiting, injecting, injection, interact, interfere, investigation, kidney, killed, lessened, leukemia, Leverage, local, lymphoma, male, malignant, manage, marked, marrow, measuring, Medidata, melanoma, merger, metastasize, MIR, mortality, mouth, Nasdaq, negotiate, oral, Originally, ovarian, permeability, permit, Pharmacia, pharmacological, plasma, PLATINOL, predisposition, prescribed, PROH, proliferating, proven, PTO, pyrimidine, radioactive, ranging, rash, receiving, receptive, rectum, reformulate, Reformulation, regression, renal, rental, represented, resigned, respond, retail, reviewing, RNA, Roche, Russia, secondary, size, skin, SmallCap, smaller, smoking, sooner, speed, spouse, Standardization, stomach, strategy, studied, studying, suffering, superceded, suppression, survival, susceptible, system, systemic, Taxol, testicular, thyroid, tolerate, Toxikon, treated, unbalanced, uncontrolled, undergo, undesired, upgrade, upgraded, Upjohn, variety, Verify, vomiting, voting, Welfare, Wilmington, worldwide

Galectin Therapeutics (GALT) 10-K2005 FY Annual report

Content analysis